Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABSORB: Initial Clinical Experience With the Everolimus-eluting Bioresorbable Vascular Scaffold (BVS) System in the Treatment of de Novo Native Coronary Artery Lesions - a Surveillance Registry

NCT01583608 is registered in ClinicalTrials.gov with Medical Care Center Prof. Mathey, Prof. Schofer, Ltd. as lead sponsor.

NCT NCT01583608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01583608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ABSORB: Initial Clinical Experience With the Everolimus-eluting Bioresorbable Vascular Scaffold (BVS) System in the Treatment of de Novo Native Coronary Artery Lesions - a Surveillance Registry
Lead sponsor
Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.
Phase
Observational
Overall status
Completed
Start date
April 30, 2012
Completion date
June 30, 2016
Enrollment
183 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive diseases, arteriosclerosis, cardiovascular diseases, coronary artery disease, coronary disease, coronary restenosis, coronary stenosis, heart diseases, myocardial ischemia, vascular diseases